Education:
|
1961-65 |
University
of Oregon, Eugene, Oregon (BA) |
|
1965-69 |
University
of Oregon Medical School, Portland, Oregon (MD) |
Postgraduate
Training:
|
1969-70 |
Intern,
Medicine, Barnes Hospital, St. Louis, Missouri |
|
1970-74 |
Resident,
Obstetrics and Gynecology, Harbor
General Hospital, Torrance, California |
|
1974-75 |
Postdoctoral
Fellowship, Reproductive Endocrinology, Division of Reproductive
Biology, Obstetrics and Gynecology, Harbor General Hospital,
Torrance, California |
|
1975-77 |
Postdoctoral
Fellowship, Reproductive Endocrinology, Reproductive
Endocrinology Center, Obstetrics and Gynecology, University of
California Medical Center, San Francisco, CA |
Academic
Appointments:
|
1977-86 |
Department of Obstetrics and Gynecology, UCLA School of
Medicine, Los Angeles, California |
|
1986-96 |
Department of Obstetrics and Gynecology, UCD School of Medicine, Davis, California |
|
1987-96 |
Chair, Department of Obstetrics and Gynecology, UCD School of Medicine, Davis, California |
|
1997- |
Department of Reproductive Medicine, UCSD School of
Medicine, La Jolla, California |
Professional
Certifications:
|
1970 |
National
Board of Medical Examiners |
|
1971 |
State
of California Board of Medical Examiners (Lic#G20109) |
|
1977 |
Diplomat
of the American Board of Obstetrics and Gynecology |
|
1980 |
Diplomat
of the American Board of Obstetrics and Gynecology,
Subspecialty of Reproductive Endocrinology |
|
1994 |
American
Board of Obstetrics and Gynecology, Recertification |
|
1994 |
American
Board of Obstetrics and Gynecology, Subspecialty of
Reproductive Endocrinology, Recertification |
Professional
Membership/Service:
NIH Reproductive
Biology Study Section Member 1989-1993, Chair 1989-1993; NIH
Physiological Sciences Review Section Administrative, Chair 1991-1993;
American Board of Obstetrics and Gynecology Examiner, Subspecialty
Board (Reproductive Endocrinology) 1992-Present; American College of
Obstetricians and Gynecologists GYN Practice Committee Chair 1994-95,
Subcommittee on Reproductive Endocrinology Practice Chair 1991-93,
1997-99, Document Review Panel on Gynecology Vice-Chair 2001-02, ACOG
Section I, District IX Chair 1993-96; Pacifici Coast Reproductive
Society President 1989-90; Society of Reproductive Endocrinologyists
President 1990-92; Association of Professors of Gynecology and
Obstetrics President 1994-95; American Society from Reproductive
Medicine President 1999-2000.
Selected
Publications (From a Total of 170 Published or In Press;
1974 - Present):
Chang RJ, Mandel FP, Lu KH, Judd HL.
Enhanced disparity of gonadotropin secretion by estrone in women
with polycystic ovarian disease. J Clin Endocrinol Metab
54:490-494, 1982.
Chang RJ, Mandel FP, Wolfsen AR, Judd HL.
Circulating levels of plasma adrenocorticotropin in polycystic
ovary disease. J Clin Endocrinol Metab
54:1265-1267, 1982.
Chang RJ, Laufer LR, Meldrum DR, DeFazio J, Lu KH, Vale WW,
Rivier JE, Judd HL. Steroid
secretion in polycystic ovarian disease after ovarian suppression with
a long-acting gonadotropin-releasing hormone agonist.
J Clin Endocrinol Metab 56:897-903,
1983.
Chang RJ, Nakamura R, Judd HL, Kaplan SA.
Insulin resistance in non-obese patients with polycystic ovarian
disease. J Clin Endocrinol
Metab 57:356-359, 1983.
Chang RJ. Ovarian
steroid secretion in polycystic ovarian disease. Sem Reprod Endocrinol 2:244-250,
1984.
Geffner
ME, Kaplan SA, Bersch N, Golde DW, Landlaw EM, Chang
RJ. Persistence of
insulin resistance in polycystic ovarian disease after inhibition of
ovarian steroid secretion. Fertil
Steril 45:327-333, 1986.
Steingold
K, de Ziegler D, Cedar M, Meldrum DR, Lu KH, Vale WW, Rivier JE, Judd
HL, Chang RJ. Clinical and hormonal effects of chronic long-acting
gonadotropin-releasing hormone agonist treatment in polycystic ovarian
disease. J Clin Endocrinol
Metab 65:773-778, 1987.
de
Ziegler D, Steingold K, Cedars M, Lu KH, Judd HL, Chang
RJ. Recovery of
hormone secretion after chronic gonadotropin-releasing hormone agonist
administration in women with polycystic ovarian disease.
J Clin Endocrinol Metab 68:1111-1117,
1989.
Erickson
GF, Magoffin DA, Cragun JR, Chang
RJ. The effect of insulin and insulin-like growth factors I and II
on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab 70:894-902, 1990.
Cedars
MI, Steingold KA, de Ziegler D, Lapolt PS, Chang
RJ, Judd HL. Long-term administration of gonadotropin-releasing
hormone agonist and dexamethasone: assessment of the adrenal role in
ovarian dysfunction. Fertil
Steril 57:495-500, 1992.
Erickson
GF, Magoffin DA, Garzo G, Cheung AP, Chang
RJ. Granulosa cells of
polycystic ovaries: are they normal or abnormal?
Hum Reprod 7:293-299,
1992.
Chang RJ, Cragun JR. Surgical
and medical treatment of polycystic ovary syndrome.
In A Dunaif, J Givens, G Merriam, F Haseltine (eds) Polycystic
Ovary Syndrome. Current
Issues in Endocrinology and Metabolism Series, Blackwell Scientific
Publications, Inc., 1992.
Cheung
AP, Chang RJ. Pituitary
responsiveness to gonadotropin-releasing hormone agonist stimulation: a
dose-response comparison of LH/FSH secretion in women with polycystic
ovary syndrome and normal women. Hum
Reprod 10:1054-1059, 1995.
Cheung
AP, Lu JKH, Chang RJ.
Hypothalamic-pituitary dynamics in polycystic ovary syndrome.
In RJ Chang (ed) Polycystic Ovary Syndrome,
Springer-Verlag New York, Inc., 1996.
Chang RJ.
Polyceptic ovary syndrome - diagnostic criteria. In RJ Chang, JJ
Weindel, A Dunaif (eds) Polycystic Ovary Syndrome Marcel Dekker New
York, 2002.
|
